Lilly Eli & Co

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Lilly Eli & Co
TickerLLY
CIK #0000059478
CUSIP532457108
SectorLife Sciences - Pharmaceutical Preparations
AddressLilly Corporate Ctr Drop Code 1112, Indianapolis, IN 46285
Source [EDGAR]
CIK Filing 2011 - 2025
[0000059478] 10-K
[0000059478] 10-Q
[0000059478] 3
[0000059478] 4
[0000059478] 5
[0000059478] 8-K
[0000059478] SC 13D
[0000059478] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Eli Lilly & Co Sigilon Therapeutics Inc [2023-07-07] 40.3
Eli Lilly & Co Akouos Inc [2022-10-27] 25.5
Eli Lilly & Co Immunocore Holdings PLC [2022-02-10] 5.8
Eli Lilly & Co Foghorn Therapeutics Inc [2021-12-13] 0.7
Eli Lilly & Co Proqr Therapeutics NV [2021-09-10] 5.6
Eli Lilly & Co AC Immune Sa [2021-02-12] 5.0
Eli Lilly & Co Sigilon Therapeutics Inc [2021-02-12] 8.8
Eli Lilly & Co Avidity Biosciences Inc [2021-02-12] 6.2
Eli Lilly & Co Precision Biosciences Inc [2021-01-08] 7.165
Eli Lilly & Co Prevail Therapeutics Inc [2020-12-22] 53.3
PNC Financial Services Group Inc Eli Lilly & Co [2020-02-14] 5.43
Eli Lilly & Co Dermira Inc [2020-01-10] 12.9
Lilly Eli & Co Elanco Animal Health Inc [2019-02-14] 80.2
Lilly Eli & Co Loxo Oncology Inc [2019-01-15] 6.6
Lilly Eli & Co Dicerna Pharmaceuticals Inc [2018-12-20] 8.6
Lilly Eli & Co Zymeworks Inc [2018-02-14] 15.6
Lilly Eli & Co LEAP Therapeutics Inc [2017-11-22] 17.5
Wellington Management Group LLP Lilly Eli & Co [2017-02-09] 5.15
Lilly Eli & Co Colucid Pharmaceuticals Inc [2017-01-27] 35.0
Lilly Eli & Co Lilly Eli & Co [2016-04-22] 19.2
Vanguard Group Inc Lilly Eli & Co [2016-02-11] 5.4
Lilly Eli & Co Ignyta Inc [2015-11-16] 8.4
Lilly Eli & Co Cerulean Pharma Inc [2015-02-17] 11.7
Lilly Eli & Co Zosano Pharma Corp [2015-02-09] 11.5
Lilly Eli & Co Coherus Biosciences Inc [2014-11-24] 0.1
PRIMECAP Management Co/CA/ Lilly Eli & Co [2014-03-07] 5.0
Wellington Management Co LLP Lilly Eli & Co [2014-02-14] 5.64
Form 3/4/5 Filer 2011 - 2025
ELI LILLY & Co
Luciano Juan R
Hedley Mary Lynne
Fyrwald J Erik
Alvarez Ralph
Sulzberger Gabrielle
Montarce Lucas
Van Naarden Jacob
Yuffa Ilya
Skovronsky Daniel
Ricks David A
Jackson Jamere
Seymour Melissa
Lilly Endowment Inc
Custer Kenneth L.
Zakrowski Donald A
Hakim Anat
Hernandez Edgardo
Dozier Eric
White Anne E.
Rau Diogo
Jonsson Patrik
Johnson Kimberly H
Moeller Jon R
Baicker Katherine
Walker Karen
Kaelin William G Jr
Brooks Gordon J.
Norton Johna
Ashkenazi Anat
Weems Alonzo
Runge Marschall S
Shenandoah Acquisition Corp
Sigilon Therapeutics, Inc.
Tai Jackson P
Mason Michael B
Pusey Leigh Ann
Kearny Acquisition Corp
Akouos, Inc.
Fry Stephen F
Eskew Michael L
Zulueta Alfonso G
Smiley Joshua L
Shah Aarti S.
O'Neill Myles
Barnes Melissa S
Tyto Acquisition Corp
Prevail Therapeutics Inc.
Seifert Kathi P
Bertozzi Carolyn R
Avidity Biosciences, Inc.
Dermira, Inc.
Bald Eagle Acquisition Corp
Harrington Michael J
Shaw Christi
Marram Ellen R
Elanco Animal Health Inc
Conterno Enrique A
Zymeworks BC Inc.
Simmons Jeffrey N
LEAP Therapeutics Inc
Mahony Susan
Lundberg Jan M
Crowe Maria A
Rice Derica W
Lechleiter John C
Hoover R David
Prendergast Franklyn G
CoLucid Pharmaceuticals, Inc.
ProCar Acquisition Corp
Peterson Barton R
Walsh Fionnuala M
Spyre Therapeutics, Inc.
Horn Karen N
Zosano Pharma Corp
Oberhelman Douglas R
Lilly Ventures Fund I LLC
Coherus Oncology, Inc.
Dare Bioscience, Inc.
Tapiero Jacques
Bischoff Winfried F W Sir
Gilman Alfred G
Armitage Robert A
Nobles Anne
Hanish Arnold C
Carmine Bryce D.
Deane Frank M
Form 13F Holdings
Firm Period DFND Voting Shares
Lilly Endowment Inc [2025-06-30] SOLE 96,016,978 96,016,978
Vanguard Group Inc [2025-06-30] SOLE 0 76,528,771
BlackRock, Inc. [2025-06-30] SOLE 59,449,406 66,056,006
PNC Financial Services Group Inc [2025-06-30] DFND 1,050,029 51,077,044
State Street Corp [2025-06-30] DFND 20,243,112 34,506,968
FMR LLC [2025-06-30] DFND 23,392,767 25,629,773
Capital Research Global Investors [2025-06-30] DFND 20,746,317 20,756,363
Geode Capital Management LLC [2025-06-30] DFND 18,111,024 18,128,627
Capital World Investors [2025-06-30] DFND 17,581,381 17,634,492
Morgan Stanley [2025-06-30] DFND 7,269,733 14,868,496
Wellington Management Group LLP [2025-06-30] DFND 0 13,989,551
JPMorgan Chase & Co [2025-06-30] DFND 10,238,788 12,445,168
Bank of America Corp /DE/ [2025-06-30] DFND 1,419,130 12,185,666
PRIMECAP Management Co/CA/ [2025-06-30] SOLE 11,913,931 12,154,908
Norges Bank [2025-06-30] SOLE 11,324,406 11,324,406
Capital International Investors [2025-06-30] DFND 9,397,273 9,422,128
State Farm Mutual Automobile Insurance Co [2025-06-30] SOLE 9,090,106 9,090,106
Northern Trust Corp [2025-06-30] DFND 8,268,045 8,470,594
Susquehanna International Group LLP [2025-06-30] OTR 212,045 6,720,745
Citadel Advisors LLC [2025-06-30] DFND 6,313,252 6,313,252
Goldman Sachs Group Inc [2025-06-30] DFND 5,212,446 5,916,611
Nuveen, LLC [2025-06-30] DFND 5,663,174 5,689,733
Charles Schwab Investment Management Inc [2025-06-30] SOLE 5,359,427 5,359,653
Jennison Associates LLC [2025-06-30] DFND 4,868,922 5,322,707
Legal & General Group Plc [2025-06-30] DFND 4,786,182 5,229,285
AllianceBernstein LP [2025-06-30] DFND 4,867,494 5,213,854
Bank of New York Mellon Corp [2025-06-30] DFND 3,995,713 5,095,401
Franklin Resources Inc [2025-06-30] DFND 4,706,978 4,765,662
UBS Group AG [2025-06-30] DFND 1,828,795 4,528,046
Janus Henderson Group PLC [2025-06-30] DFND 0 4,384,862
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com